Profile
| Metric | Value |
|---|---|
| Full Name | ProQR Therapeutics N.V. |
| Ticker | NASDAQ: PRQR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Netherlands |
| IPO | |
| Indexes | Not included |
| Website | proqr.com |
| Employees | 166 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1.68 | |
| Price, 1D Change | -5.08% | |
| $177M | ||
| - | ||
| - | ||
| 1.04 | ||
| $20M | ||
| Revenue, 1Y Change | +190.38% | |
| -$0.35 | ||
| EPS, 1Y Change | +7.06% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.35 | ||
| EPS Estimate | -$0.49 | |
| EPS Est. Change | -39.33% | |
| $20.45M | ||
| Revenue Estimate | $19.65M | |
| Revenue Est. Change | -3.91% | |
| Current Price | $1.68 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.27 | -$0.38 | -39.00% | |
| -$0.50 | -$0.35 | +30.10% | |
| -$0.49 | N/A | -39.33% | |
| -$0.62 | N/A | -76.95% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $18.57M | $7.04M | -62.08% | |
| $22.07M | $20.45M | -7.33% | |
| $19.65M | N/A | -3.91% | |
| $20.15M | N/A | -1.45% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $1.68 | |
| $2.04 | ||
| SMA 200 vs Price | +21.49% | |
| $2.18 | ||
| SMA 50 vs Price | +29.51% | |
| 1.04 | ||
| $0.18 | ||
| 32.43 | ||
| 90.22% | ||
| 73.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $20.45M | ||
| -$0.35 | ||
| $17.46M | ||
| 85.40% | ||
| -$33.65M | ||
| -164.57% | ||
| -$30.03M | ||
| -146.86% | ||
| -$30.67M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.18 | ||
| 3.95 | ||
| 3.95 | ||
| - | ||
| 2 | ||
| -1.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 10.38 | ||
| 2.64 | ||
| -1.46 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $92.15M | ||
| $155.47M | ||
| $173.92M | ||
| $160.09M | ||
| $82.22M | ||
| $40.48M | ||
| $16.08M | ||
| $4.62M | ||
| $16.60K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $50.48M | ||
| $51.12M | ||
| $2.99M | ||
| $0.00 | ||
| $2.99M | ||
| $0.00 | ||
| -$213.10K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$39.37M | ||
| -$4.41M | ||
| $76.02M | ||
| $4.41M | ||
| -$43.77M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | → | |
| Chardan Capital | → | |
| JMP Securities | → | |
| Cantor Fitzgerald | → | |
| Oppenheimer | → | |
| Evercore ISI Group | ||
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Jones Trading | ||
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with PRQR
Data Sources & References
- PRQR Official Website www.proqr.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1612940/000110465925107349/0001104659-25-107349-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1612940/000155837025002851/0001558370-25-002851-index.htm
- PRQR Profile on Yahoo Finance finance.yahoo.com/quote/PRQR
- PRQR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/prqr
FAQ
What is the ticker symbol for ProQR Therapeutics N.V.?
The ticker symbol for ProQR Therapeutics N.V. is NASDAQ:PRQR
Does ProQR Therapeutics N.V. pay dividends?
No, ProQR Therapeutics N.V. does not pay dividends
What sector is ProQR Therapeutics N.V. in?
ProQR Therapeutics N.V. is in the Healthcare sector
What industry is ProQR Therapeutics N.V. in?
ProQR Therapeutics N.V. is in the Biotechnology industry
What country is ProQR Therapeutics N.V. based in?
ProQR Therapeutics N.V. is headquartered in Netherlands
When did ProQR Therapeutics N.V. go public?
ProQR Therapeutics N.V. initial public offering (IPO) was on September 18, 2014
Is ProQR Therapeutics N.V. in the S&P 500?
No, ProQR Therapeutics N.V. is not included in the S&P 500 index
Is ProQR Therapeutics N.V. in the NASDAQ 100?
No, ProQR Therapeutics N.V. is not included in the NASDAQ 100 index
Is ProQR Therapeutics N.V. in the Dow Jones?
No, ProQR Therapeutics N.V. is not included in the Dow Jones index
When was ProQR Therapeutics N.V. last earnings report?
ProQR Therapeutics N.V.'s most recent earnings report was on November 6, 2025
When does ProQR Therapeutics N.V. report earnings?
The next expected earnings date for ProQR Therapeutics N.V. is March 12, 2026